Skip to main content
Log in

Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

Homozygous mutations in the HAX1 gene cause an autosomal recessive form of severe congenital neutropenia (SCN). There are limited data on cases of gonadal insufficiency that involve the HAX1 gene mutation. We aimed to evaluate the pubertal development and gonadal functions of our patients with a p.Trp44X mutation in the HAX1 gene.

Method

Pubertal development, physical and laboratory findings of one male and seven female patients with HAX1 deficiency were evaluated.

Results

The age of the patients was between 13 and 25 years. All female patients were diagnosed with primary ovarian insufficiency (POI) based on amenorrhea and elevated gonadotropins. The ovary volumes in female patients were determined to be smaller than normal for their age through sonographic studies. Short stature associated with gonadal insufficiency was also observed in three patients.

Conclusion

The HAX1 gene is important for ovarian development, in which a p.Trp44X mutation may cause POI in female patients. It is crucial to follow up and evaluate the gonadal functions of female patients in such cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kostman R. Infantile genetic agranulocytosis. A new recessive lethal disease in man. Acta Paediatr Scand. 1956;45:1–78.

    Article  Google Scholar 

  2. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86–92.

    Article  CAS  Google Scholar 

  3. Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health. 2014;6:235–43.

    PubMed  PubMed Central  Google Scholar 

  4. Nelson LM. Primary ovarian insufficiency. N Engl JMed. 2009;360:606–14.

    Article  CAS  Google Scholar 

  5. Carlsson G, Kriström B, Nordenskjöld M, Henter JI, Fadeel B. Ovarian failure in HAX1-deficient patients: is there a gender-specific difference in pubertal development in severe congenital neutropenia or Kostmann disease? Acta Paediatr. 2013;102:78–82.

    Article  CAS  Google Scholar 

  6. Gilsanz V, Ratib O. Hand bone age: a digital atlas of skeletal maturity. 2nd ed. New York: Springer; 2012.

    Book  Google Scholar 

  7. Hanew K, Utsumi A. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. Eur J Endocrinol. 2002;146:197–202.

    Article  CAS  Google Scholar 

  8. Hilczer M, Smyczynska J, Lewinski A. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature. Endocr Regul. 2006;40:69–75.

    CAS  PubMed  Google Scholar 

  9. Hauck F, Klein C. Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol. 2013;13:596–606.

    Article  CAS  Google Scholar 

  10. Smith BN, Ancliff PJ, Pizzey A, Khwaja A, Linch DC, Gale RE. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol. 2009;144:762–70.

    Article  CAS  Google Scholar 

  11. Ishikawa N, Okada S, Miki M, Shirao K, Kihara H, Tsumura M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet. 2008;45:802–7.

    Article  CAS  Google Scholar 

  12. Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008;111:4954–7.

    Article  CAS  Google Scholar 

  13. Roques G, Munzer M, Barthez MA, et al. Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations. Pediatr Blood Cancer. 2014;61:1041–8.

    Article  CAS  Google Scholar 

  14. Carlsson G, van’t Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 2008;264:388–400.

    Article  CAS  Google Scholar 

  15. Lees DM, Hart IR, Marshall JF. Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues. J Mol Biol. 2008;379:645–55.

    Article  CAS  Google Scholar 

  16. Kilpinen S, Autio R, Ojala K, et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol. 2008;9:R139.

    Article  Google Scholar 

  17. Grzybowska EA, Sarnowska E, Konopiński R, Wilczyńska A, Sarnowski TJ, Siedlecki JA. Identification and expression analysis of alternative splice variants of the rat HAX-1 gene. Gene. 2006;371:84–92.

    Article  CAS  Google Scholar 

  18. Langer JE, Oliver ER, Lev-Toaff AS, Coleman BG. Imaging of the female pelvis through the life cycle. Radiographics. 2012;32:1575–97.

    Article  Google Scholar 

  19. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott–Raven; 1996. p. 1393–410.

    Google Scholar 

  20. Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014;124:193–7.

  21. Rogol AD. Sex steroids, growth hormone, leptin and the pubertal growth spurt. Endocr Dev. 2010;17:77–85.

    Article  CAS  Google Scholar 

  22. Kawai N, Kanzaki S, Watou ST, et al. Serum free insulin-like growth factor I (IGF-1), total IGF-1 and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency. J Clin Endocrinol Metab. 1999;84:82–9.

    CAS  PubMed  Google Scholar 

  23. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771–81.

    Article  CAS  Google Scholar 

  24. Kanbur-Oksüz N, Derman O, Kinik E. Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages. Turk J Pediatr. 2004;46:315–21.

    PubMed  Google Scholar 

  25. Cook JS, Hoffman RP, Stene MA, Hansen JR. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab. 1993;77:725–30.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported through “The Scientific and Technological Research Council of Turkey (TUBITAK)”. TUBITAK-Project No.: SBAG-HD-650 (110S513).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara S. Kilic.

Ethics declarations

The study was approved by the ethical committee of the Uludag University Faculty of Medicine.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cekic, S., Saglam, H., Gorukmez, O. et al. Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation. J Clin Immunol 37, 524–528 (2017). https://doi.org/10.1007/s10875-017-0412-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-017-0412-8

Keywords

Navigation